Krystal Biotech, Inc. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2022-02-28: Form 10-K; Item Smaller reporting company; As filed Yes.
- 2022-02-28: Form 10-K; Item Well-known seasoned issuer; As filed No.
- 2021-11-08: Form 10-Q; Item Smaller reporting company; As filed Yes.
- 2021-11-08: Form 10-Q; Item Emerging growth company; As filed Yes.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2022-02-28 | 10-K | Smaller reporting company | Yes |
| 2022-02-28 | 10-K | Well-known seasoned issuer | No |
| 2021-11-08 | 10-Q | Smaller reporting company | Yes |
| 2021-11-08 | 10-Q | Emerging growth company | Yes |
| 2021-08-09 | 10-Q | Smaller reporting company | Yes |
| 2021-08-09 | 10-Q | Emerging growth company | Yes |
| 2021-05-10 | 10-Q | Smaller reporting company | Yes |
| 2021-05-10 | 10-Q | Emerging growth company | Yes |
| 2021-03-01 | 10-K | Smaller reporting company | Yes |
| 2021-03-01 | 10-K | Emerging growth company | Yes |
| 2021-03-01 | 10-K | Well-known seasoned issuer | No |
| 2020-11-09 | 10-Q | Smaller reporting company | Yes |
| 2020-11-09 | 10-Q | Emerging growth company | Yes |
| 2020-08-07 | 10-Q | Smaller reporting company | Yes |
| 2020-08-07 | 10-Q | Emerging growth company | Yes |
| 2020-05-04 | 10-Q | Smaller reporting company | Yes |
| 2020-05-04 | 10-Q | Emerging growth company | Yes |
| 2020-03-10 | 10-K | Smaller reporting company | Yes |
| 2020-03-10 | 10-K | Emerging growth company | Yes |
| 2020-03-10 | 10-K | Well-known seasoned issuer | No |
| 2019-11-04 | 10-Q | Smaller reporting company | Yes |
| 2019-11-04 | 10-Q | Emerging growth company | Yes |
| 2019-08-05 | 10-Q | Smaller reporting company | Yes |
| 2019-08-05 | 10-Q | Emerging growth company | Yes |
| 2019-05-07 | 10-Q | Smaller reporting company | Yes |
| 2019-05-07 | 10-Q | Emerging growth company | Yes |
| 2018-11-05 | 10-Q | Smaller reporting company | Yes |
| 2018-11-05 | 10-Q | Emerging growth company | Yes |
| 2018-03-12 | 10-K | Well-known seasoned issuer | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |